Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale

Rhea-AI Filing Summary

Bausch Health Companies Inc. executive vice president and general counsel Seana Carson reported several equity transactions in company common shares. Carson received an award of 212,350 restricted share units (RSUs), which will vest in three equal annual installments, with vested RSUs settled in common shares.

To cover tax withholding on a prior RSU vesting, 32,211 common shares were withheld and disposed of at $6.04 per share. Carson also completed an open-market sale of 8,388 common shares at $5.95 per share pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on May 7, 2025. After these transactions, Carson directly holds 809,258 common shares of Bausch Health.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carson Seana

(Last) (First) (Middle)

400 SOMERSET CORPORATE BOULEVARD

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/25/2026		A		212,350(1)	A	$0	849,857	D
Common Shares, No Par Value	02/26/2026		F		32,211(2)	D	$6.04	817,646	D
Common Shares, No Par Value	02/27/2026		S		8,388(3)	D	$5.95	809,258	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

2. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

3. Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 7, 2025.

	/s/ Brianna M. Dorsi attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Bausch Health (BHC) report for Seana Carson?

Bausch Health reported that Seana Carson received 212,350 RSUs, had 32,211 shares withheld for taxes on a vesting event, and sold 8,388 common shares in the open market under a Rule 10b5-1 trading plan.

How many Bausch Health shares does Seana Carson own after these Form 4 transactions?

After the reported transactions, Seana Carson directly owns 809,258 Bausch Health common shares. This figure reflects the RSU grant, the tax-withholding share disposition, and the 8,388-share open-market sale disclosed in the Form 4 filing.

What are the terms of Seana Carson’s 212,350 Bausch Health RSU award?

The 212,350 restricted share units granted to Seana Carson vest in three equal installments. One-third vests on each of the first three anniversaries of the grant date, assuming continued service, and vested RSUs settle in Bausch Health common shares.

Why were 32,211 Bausch Health shares disposed of in Carson’s Form 4 filing?

The 32,211 Bausch Health shares were withheld to satisfy tax withholding obligations from the vesting of restricted share units. This tax-withholding disposition is a non-open-market transaction used to cover required tax liabilities on the equity award.

Was Seana Carson’s Bausch Health share sale under a Rule 10b5-1 plan?

Yes. The Form 4 footnotes state that the 8,388 Bausch Health common shares were sold in the open market under a Rule 10b5-1 trading plan that Carson adopted on May 7, 2025, providing a pre-arranged framework for the sale.

At what prices were Seana Carson’s Bausch Health share transactions executed?

The tax-withholding disposition of 32,211 shares occurred at $6.04 per share. The open-market sale of 8,388 common shares under the Rule 10b5-1 plan was executed at $5.95 per share, according to the reported transaction details.